Amedisys Home Health and Hospice Care (AMED) Upgraded to Strong-Buy by BidaskClub

BidaskClub upgraded shares of Amedisys Home Health and Hospice Care (NASDAQ:AMED) from a buy rating to a strong-buy rating in a research note released on Friday.

AMED has been the subject of a number of other reports. Zacks Investment Research cut Amedisys Home Health and Hospice Care from a buy rating to a hold rating in a research note on Friday, January 19th. Royal Bank of Canada raised Amedisys Home Health and Hospice Care from a sector perform rating to an outperform rating in a research note on Monday, March 19th. Jefferies Group set a $70.00 price target on Amedisys Home Health and Hospice Care and gave the company a buy rating in a research note on Wednesday, February 28th. Oppenheimer increased their target price on Amedisys Home Health and Hospice Care from $68.00 to $63.00 and gave the stock an outperform rating in a research note on Thursday, March 1st. Finally, Robert W. Baird set a $66.00 target price on Amedisys Home Health and Hospice Care and gave the stock a hold rating in a research note on Thursday, March 1st. Five equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Amedisys Home Health and Hospice Care presently has a consensus rating of Buy and an average target price of $63.18.

How to Become a New Pot Stock Millionaire

Shares of AMED stock traded down $1.08 on Friday, reaching $64.45. The company had a trading volume of 147,802 shares, compared to its average volume of 224,205. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.45 and a quick ratio of 1.45. The stock has a market cap of $2,227.02, a PE ratio of 29.16, a price-to-earnings-growth ratio of 1.25 and a beta of 0.65. Amedisys Home Health and Hospice Care has a 12 month low of $45.60 and a 12 month high of $65.91.

Amedisys Home Health and Hospice Care (NASDAQ:AMED) last announced its quarterly earnings results on Tuesday, February 27th. The health services provider reported $0.56 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.02). The company had revenue of $404.24 million during the quarter, compared to the consensus estimate of $394.96 million. Amedisys Home Health and Hospice Care had a net margin of 1.98% and a return on equity of 15.14%. During the same period last year, the company earned $0.44 earnings per share. research analysts anticipate that Amedisys Home Health and Hospice Care will post 3 earnings per share for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Copper Rock Capital Partners LLC increased its stake in Amedisys Home Health and Hospice Care by 3.6% during the 4th quarter. Copper Rock Capital Partners LLC now owns 596,014 shares of the health services provider’s stock worth $31,386,000 after purchasing an additional 20,699 shares in the last quarter. Sterling Capital Management LLC increased its stake in Amedisys Home Health and Hospice Care by 15.8% during the 3rd quarter. Sterling Capital Management LLC now owns 16,654 shares of the health services provider’s stock worth $932,000 after purchasing an additional 2,268 shares in the last quarter. Strs Ohio bought a new stake in Amedisys Home Health and Hospice Care during the 4th quarter worth approximately $1,027,000. Mitsubishi UFJ Asset Management UK Ltd. boosted its position in Amedisys Home Health and Hospice Care by 15.6% during the 4th quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 22,200 shares of the health services provider’s stock worth $1,170,000 after acquiring an additional 3,000 shares during the last quarter. Finally, Arizona State Retirement System boosted its position in Amedisys Home Health and Hospice Care by 224.8% during the 4th quarter. Arizona State Retirement System now owns 47,913 shares of the health services provider’s stock worth $2,525,000 after acquiring an additional 33,163 shares during the last quarter. 96.71% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Amedisys Home Health and Hospice Care (AMED) Upgraded to Strong-Buy by BidaskClub” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3338369/amedisys-home-health-and-hospice-care-amed-upgraded-to-strong-buy-by-bidaskclub.html.

Amedisys Home Health and Hospice Care Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Analyst Recommendations for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Receive News & Ratings for Amedisys Home Health and Hospice Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Home Health and Hospice Care and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Novartis  Posts Quarterly  Earnings Results, Beats Expectations By $0.03 EPS
Novartis Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS
Omnicom Group  Posts Quarterly  Earnings Results, Beats Estimates By $0.08 EPS
Omnicom Group Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS
Textron  Posts Quarterly  Earnings Results, Beats Estimates By $0.24 EPS
Textron Posts Quarterly Earnings Results, Beats Estimates By $0.24 EPS
Alpine Global Premier  to Issue Monthly Dividend of $0.05 on  April 30th
Alpine Global Premier to Issue Monthly Dividend of $0.05 on April 30th
IBM  Updates FY18 Earnings Guidance
IBM Updates FY18 Earnings Guidance
Boulder Growth & Income Fund Inc Announces Monthly Dividend of $0.03
Boulder Growth & Income Fund Inc Announces Monthly Dividend of $0.03


Leave a Reply

© 2006-2018 Ticker Report. Google+.